XENE - Xenon Pharmaceuticals Inc.

QQQ $ 602.31 $ 4.71 (0.79 %)

DIA $ 460.91 $ 1.55 (0.34 %)

SPY $ 662.56 $ 3.09 (0.47 %)

TLT $ 90.94 $ -0.30 (-0.33 %)

GLD $ 389.22 $ -7.97 (-2.01 %)

Previous Close

$ 42.17

Open

$ 42.00

Bid

$ 42.35 x 1

Ask

$ 42.40 x 100

Day's Range

$ 42.00 - $ 42.75

52 Week Range

$ 26.74 - $ 46.00

Volume

805,287

Average Volume

Market Cap

3.25B

Beta (5Y Monthly)

$ 0.80

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-11-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	02-27-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-01-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	03-01-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-11-2021	06-30-2021	10-Q
18	05-11-2021	03-31-2021	10-Q
19	03-01-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-21-2020	03-31-2020	10-Q
23	03-09-2020	12-31-2019	10-K
24	11-05-2019	09-30-2019	10-Q
25	08-06-2019	06-30-2019	10-Q
26	05-07-2019	03-31-2019	10-Q
27	03-06-2019	12-31-2018	10-K
28	11-06-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-08-2018	03-31-2018	10-Q
31	03-07-2018	12-31-2017	10-K
32	11-07-2017	09-30-2017	10-Q
33	08-03-2017	06-30-2017	10-Q
34	05-09-2017	03-31-2017	10-Q
35	03-08-2017	12-31-2016	10-K
36	11-03-2016	09-30-2016	10-Q
37	08-03-2016	06-30-2016	10-Q
38	05-10-2016	03-31-2016	10-Q
39	03-08-2016	12-31-2015	10-K
40	11-10-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Xenon Pharmaceutical Appoints Tucker Kelly...
10/16/2025 12:32:14

VANCOUVER, British Columbia and BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neurosci...

Chardan Capital Maintains Buy on Xenon Pha...
10/07/2025 11:45:44

Chardan Capital analyst Rudy Li maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and maintains $55 price target.

Wells Fargo Assumes Xenon Pharmaceuticals ...
09/03/2025 12:54:29

Wells Fargo analyst Benjamin Burnett assumes Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight rating and announces Pric...

RBC Capital Reiterates Outperform on Xenon...
09/02/2025 13:30:13

RBC Capital analyst Brian Abrahams reiterates Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and maintains $55 price ...

Chardan Capital Maintains Buy on Xenon Pha...
08/12/2025 20:30:47

Chardan Capital analyst Rudy Li maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and maintains $55 price target.

RBC Capital Maintains Outperform on Xenon ...
08/12/2025 14:14:34

RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and lowers the price targ...

CORRECTION: Xenon Pharmaceuticals Q2 EPS $...
08/12/2025 13:51:46

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate ...

Wedbush Maintains Outperform on Xenon Phar...
08/12/2025 13:27:02

Wedbush analyst Laura Chico maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and raises the price target from...

Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

A Look Ahead: Xenon Pharmaceuticals's Earn...
08/08/2025 14:07:07

Xenon Pharma Added To Russell 3000 And Rus...
06/27/2025 20:02:21

Evercore ISI Group Initiates Coverage On X...
05/14/2025 15:51:27

Evercore ISI Group analyst Cory Kasimov initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform rating a...

Wells Fargo Maintains Overweight on Xenon ...
05/13/2025 18:39:52

Wells Fargo analyst Mohit Bansal maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight and lowers the price target...

RBC Capital Maintains Outperform on Xenon ...
05/13/2025 17:21:16

RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and lowers the price targ...

crude-oil-gains-3-us-inflation-eases-in-april

Crude Oil Gains 3%; US Inflation Eases In ...
05/13/2025 17:11:19

HC Wainwright & Co. Reiterates Buy on Xeno...
05/13/2025 12:36:06

HC Wainwright & Co. analyst Douglas Tsao reiterates Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and maintains $53 pri...

Needham Maintains Buy on Xenon Pharmaceuti...
05/13/2025 12:05:29

Needham analyst Serge Belanger maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and lowers the price target from $60...

Chardan Capital Maintains Buy on Xenon Pha...
05/13/2025 11:46:12

Chardan Capital analyst Rudy Li maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and maintains $55 price target.

Xenon Pharmaceuticals Q1 EPS $(0.83) Beats...
05/12/2025 20:02:05

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate of...

Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31